{site_meta && site_meta.display_name} Logo

InvestorBrandNetwork (IBN)

The latest articles, editorials and news releases from InvestorBrandNetwork (IBN), a growing Investor Brand Platform.

RSS Feed for InvestorBrandNetwork (IBN)

420 with CNW — Study Suggests Marijuana Could Boost Weight Loss, Support Metabolic Health

May 15, 2026A new preclinical investigation from the University of California, Riverside, is offering fresh insight into a puzzling trend researchers have observed for years: people who regularly use cannabis often show lower body weight and a smaller likelihood of developing type 2 diabetes, even though marijuana is widely known to stimulate hunger. Studies like these provide additional support for the conviction held by firms like Green Thumb Industries Inc.


TechMediaBreaks – Frontieras North America Inc. Developing FASForm(TM) to Unlock High-Value Fuels and Products from Coal

May 15, 2026Frontieras is positioned as global energy systems are under increasing strain as industrial demand accelerates and reliable baseload power becomes more critical to economic stability. The company “is developing a breakthrough energy-processing technology known as FASForm(TM) that deconstructs coal and other solid hydrocarbons into multiple high-value fuels and industrial products, redefining the utility and economics of coal without burning it,” reads a recent article.


InvestorNewsBreaks – Greenland Energy Company (NASDAQ: GLND) Targets Untapped East Greenland Oil Basin with 13 Billion Barrel Upside

May 15, 2026Greenland Energy (NASDAQ: GLND) is advancing a large-scale frontier oil exploration opportunity in East Greenland’s Jameson Land Basin, where it holds rights to up to a 70% working interest across more than 2 million acres. The basin, originally evaluated by ARCO but never drilled, has been estimated by independent engineering firm Sproule ERCE to contain upside potential of 13 billion recoverable barrels of oil.


InvestorNewsBreaks – Cardio Diagnostics Holdings Inc. (NASDAQ: CDIO) Poised at Intersection of Precision Medicine, Preventive Care

May 15, 2026Cardio Diagnostics Holdings (NASDAQ: CDIO), a precision medicine company leveraging epigenetics, genetics and artificial intelligence, is poised to meet demands as cardiovascular disease continues to place a profound burden on individuals, economies and healthcare systems worldwide. “Cardio Diagnostics is committed to reducing the impact of heart disease by developing a platform that integrates artificial intelligence and epigenetic and genetic biomarkers to deliver personalized cardiovascular insights from a simple blood sample, positioning itself at the intersection of precision medicine and preventive care,” reads a recent article.


CryptoNewsBreaks – Web3 and AI Take Center Stage at Blockchain Futurist Conference 2026

May 15, 2026The Blockchain Futurist Conference is set to return to Toronto on July 21-22, taking the spotlight at its flagship venue, Rebel Entertainment Complex and Cabana Pool Bar. The ninth edition conference, part of Emerald Expositions’ global portfolio, is expanding its international reach while continuing to focus on high-value networking and business development for founders, executives, investors, policymakers, and innovators.


NetworkNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Featured in NetworkNewsAudio Editorial on CNS Drug Delivery Innovation

May 15, 2026Oncotelic Therapeutics (OTCQB: OTLC) was featured in a NetworkNewsAudio audio press release focused on emerging opportunities in central nervous system drug delivery, highlighting the challenges posed by the blood-brain barrier and the company’s efforts to advance technologies designed to overcome those limitations. The editorial also noted Oncotelic’s recent strategic monetization agreement with Lunai Bioworks involving its N2B delivery system, supporting initiatives in biodefense and Alzheimer’s disease treatment.


InvestorNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Reports First-Quarter Results, Highlights Progress Across Biotech Platform

May 15, 2026Oncotelic Therapeutics (OTCQB: OTLC) reported first-quarter 2026 financial results and a corporate update highlighting continued advancement across its oncology, AI-enabled drug development and advanced drug delivery initiatives, including progress within its Sapu Nano joint venture and nose-to-brain CNS delivery platform. The company also said it maintained the previously established approximately $388 million fair value of its 45% ownership interest in GMP Biotechnology as of March 31, 2026, while continuing to pursue capital-efficient growth across its diversified biotechnology platform.


Energy Storage Helps Ford Record Its Best Daily Stock Rally in 6 Years

May 15, 2026On Wednesday, shares of Ford Motor jumped 13%, a stock movement that was its best daily performance in nearly half a decade. This jump came as the company announced that it was venturing into energy storage as a way to utilize the factory space that had previously been allocated to making EV batteries.